EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Bright Green Corporation (BGXXQ) fair value: what the stock is really worth

As of Oct 2, 2026: fair value of Bright Green Corporation $0.00, price $0.00, upside +40.0%, quality 23 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? No
  3. Add to watchlist

Health Care · US · ISIN US10920G1004

BG Bright Green Corporation logo Thin data Sep 27, 2026

Bright Green Corporation

BGXXQ · US

SpeculativeUpside exists, but weak quality makes the signal speculative.

✓Fair value $0.0003 · Undervalued (+40.0%)
!Quality 23/100
!Mixed Growth (revenue YoY +97.2 %/yr)
!Low debt · negative free cash flow
!Trails peers (2/7)
!Narrow moat 5/100
!Evidence only low, so the estimate is less certain
Watch Bright Green Corporation for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$48.08 $0.0002 Fair Value $0.0003 May 2022 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 27, 2026.

How to read this chart

53‑month range $0.0002 – $48.08 · fair‑value band $0.0003 – $0.0003 · the $0.0002 price screens below the $0.0003 fair value. Dashed = 300-day average. As of Sep 27, 2026.

Follow Bright Green in your weekly email

Every Wednesday you see whether Bright Green is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Bright Green Corporation produces and exports legal cannabis, cannabis extracts, and tetrahydrocannabinol in the United States. Its products are used in research, manufacturing, and export, as well as for production of medical cannabis products and preparations. The company was incorporated in 2019 and is based in Grants, New Mexico.

Show more

Bright Green Corporation produces and exports legal cannabis, cannabis extracts, and tetrahydrocannabinol in the United States. Its products are used in research, manufacturing, and export, as well as for production of medical cannabis products and preparations. The company was incorporated in 2019 and is based in Grants, New Mexico. On February 22, 2025, Bright Green Corporation filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of New Mexico.

Stock analysis

Bright Green Corporation (BGXXQ) currently trades at $0.0002, while our model-based Fair Value estimate is $0.0003, implying the stock looks roughly 28.6% undervalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 84/100, which puts the evidence level at low.

Scenario range: $0.0003 (bear) to $0.0003 (bull), the price of $0.0002 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 23/100 (below-average quality), in the Health Care sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Bright Green Corporation reported revenue of $401K in FY2023 versus $0 in FY2020. Reported net income was −$13.1M in FY2023.

Key figures

Market cap $7.3M · EPS (TTM) $−0.0500 · Return on equity −73.6% · Return on assets (EBIT) −49.3% · Free cash flow −$5.0M · Net debt $1.8M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 22 out of 100 (medium confidence).

What moves the price

The share trades about 96% below its 52-week high and at its 52-week low.

For context, the median of 10 Health Care peers we cover trades at −40% fair-value upside, at 40%, BGXXQ screens cheaper than that median.

Notify me when BGXXQ reaches fair value

Put BGXXQ on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 23/100

Of which business quality 26 · Market factors (momentum, volatility) 7

Profitability 0
Margins and returns on capital today
Quality Growth 91
Are margins and returns improving?
Cashflow 0
Earnings quality: real cash, not paper profit
Fin. Strength 49
Balance sheet, leverage, solvency risk
Investment 8
Disciplined investing over empire-building
Low Volatility 0
Calm price path (market factor)
Momentum 17
Price trend over the last 3–12 months (market factor)
52W Momentum 0
Distance to the 52-week high (market factor)
Net Issuance 20
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 24/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2023 is a loss year, no rate is defined from a loss
not computed

Watch BGXXQ, get fair value alerts →

Compare Bright Green Corporation with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Pharmaceuticals · 51 stocks

Beats the industry median on 2/6 measures
Overall it trails its industry peers.
Valuation
Quality Score 26 · Bottom 25%
Fair Value upside +40.0% · Above median
Profitability
Return on assets −18.6% · Bottom 25%
Operating margin (TTM) 0.0% · Bottom 25%
Growth and dividend
Revenue growth 0.0% · Below median
Balance sheet
Debt / equity 0.02× · Below median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)87 · sector 33
FUTURE (revenue growth)0 · sector 55
PAST (return on equity)0 · sector 10
HEALTH (low debt)99 · sector 98
DIVIDEND (yield)0 · sector 26

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Pharmaceuticals stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Caregen Co 214370 40,850 KRW 5,414 KRW −87%
ST Pharm Co 237690 91,700 KRW 50,110 KRW −45%
Oscotec Inc 039200 35,650 KRW 21,262 KRW −40%
DongKook Pharmaceutical Co 086450 22,150 KRW 28,372 KRW +28%
SHUKRAPHAR SHUKRAPHAR ₹55.87 ₹9.09 −84%
Huons Global Co 084110 22,950 KRW 46,562 KRW +103%
BINEX Co 053030 6,490 KRW 1,844 KRW −72%
Kolon Life Science Inc 102940 14,800 KRW 37,129 KRW +151%
VIKRAMTH VIKRAMTH ₹405.90 ₹444.16 +9%
JW Shinyak Corporation 067290 2,990 KRW 1,326 KRW −56%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Bright Green Corporation · Fair Value
$0.0003 +29%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Bright Green Corporation Fair Value". https://www.fairvalue-calculator.com/stock/BGXXQ

Frequently asked questions

Is Bright Green Corporation (BGXXQ) overvalued or undervalued?
As of Sep 27, 2026, our model estimates a fair value of $0.0003 versus a price of $0.0002, about +40% upside (undervalued).
What is the fair value of BGXXQ?
Our model-based fair value for Bright Green Corporation is $0.0003 (as of Sep 27, 2026), built from audited fundamentals. The current price: $0.0002.
What is the quality score of BGXXQ?
Bright Green Corporation has a Quality Score of 23/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Bright Green Corporation (BGXXQ)?
Our model-based price target is the fair value of $0.0003 (as of Sep 27, 2026) from 1 valuation models. Cautious scenario $0.0003, optimistic scenario $0.0003. It is a calculation from audited fundamentals, not an analyst target.
What is the Bright Green Corporation stock forecast for 2026?
Our models put fair value at $0.0003, about +40% upside versus a price of $0.0002 (undervalued). Cautious scenario $0.0003, optimistic scenario $0.0003. The calculation is refreshed regularly with new filings.
What is the intrinsic value of Bright Green Corporation (BGXXQ)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Bright Green Corporation it is $0.0003 per share (as of Sep 27, 2026), against a price of $0.0002. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Bright Green Corporation stock overvalued or undervalued in 2026?
As of Sep 27, 2026, BGXXQ trades below its calculated fair value: price $0.0002, fair value $0.0003, a gap of about +40% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of BGXXQ?
No. The price is what the market pays today ($0.0002); the fair value is what the company's own numbers justify ($0.0003). For Bright Green Corporation the two are $0.0001 per share apart. That gap is exactly why we show both numbers side by side.
How much is Bright Green Corporation worth?
The market values Bright Green Corporation at about $7.3M (market capitalisation, as of Sep 27, 2026). Per share that is $0.0002; our models calculate a fair value of $0.0003 per share.
What do the bullish and bearish scenarios say about BGXXQ?
Our models span a range for Bright Green Corporation: cautious scenario $0.0003, base $0.0003, optimistic $0.0003 per share (as of Sep 27, 2026, price $0.0002). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Bright Green Corporation (BGXXQ)?
Balance-sheet figures for Bright Green Corporation (as of Sep 27, 2026): return on equity −73.6%, debt of 0.02 per unit of equity. They feed the Quality Score of 23/100, which measures business quality independently of the share price.
How far is BGXXQ from its 52-week high?
Bright Green Corporation trades at $0.0002, about 96% below its 52-week high of $0.0050 and at the low of $0.0002 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0003 is for.
Which stocks are comparable to Bright Green Corporation?
From the same area (Health Care) we also value Caregen Co, ST Pharm Co, Oscotec Inc, DongKook Pharmaceutical Co, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Bright Green Corporation stock attractive at the current price?
The data as of Sep 27, 2026: price $0.0002, calculated fair value $0.0003 (+40%), Quality Score 23/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of BGXXQ calculated?
We run Bright Green Corporation through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0003, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Bright Green Corporation currently trades 29 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Bright Green Corporation (BGXXQ)?
The closing price on Oct 2, 2026 was $0.0002. Our model-based fair value is $0.0003, about +40% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Bright Green Corporation right now?
The large discount to fair value meets weak quality (23/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case ($0.0003). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of Bright Green Corporation

How large is the market capitalisation of Bright Green Corporation (BGXXQ)?
The market capitalisation of Bright Green Corporation is $7.3M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of Bright Green Corporation (BGXXQ)?
Earnings per share at Bright Green Corporation are $−0.0500. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of Bright Green Corporation (BGXXQ)?
The return on equity (ROE) of Bright Green Corporation is −73.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Bright Green Corporation (BGXXQ)?
On an EBIT basis the return on assets of Bright Green Corporation is −49.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
How much free cash flow does Bright Green Corporation (BGXXQ) generate?
The free cash flow of Bright Green Corporation is −$5.0M (fiscal year 2023). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Bright Green Corporation (BGXXQ) carry?
The net debt of Bright Green Corporation is $1.8M (fiscal year 2023). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Bright Green Corporation in the live analysis

One click puts Bright Green Corporation on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.